Tenet Healthcare May Benefit From Obamacare
NEW YORK (TheStreet) -- The bad news is President Obama won. The good news is Obama won. Today the big question is: With the election results final, how will you change the way you invest?My personal answer is I will invest the same way I did before. I will look for companies that analysts think will improve their revenue and earnings streams that can be bought for a reasonable price-to-earnings ratio.
Mitt Romney pledged that if he won he would start on day one to repeal Obamacare. Well, Obama won, so how can we benefit from Obamacare?
My pick here is Tenet Heathcare (THC) . In the past Tenet was hit with a lot of bad debt write-offs because it provided care to patients that were not covered by health insurance. If Obamacare kicks in, then just maybe the company may begin collecting for all the services it provides.
Some smart money in the market may feel the way I do because on Wednesday the volume of shares traded is soaring. During the past year, while the market as measured by the Value Line Index was up 10%, shares in Tenet were up 28%. During the last 30 days the stock is up more than 8%, and the hourly trading graph provided by Barchart.com shows solid price rebound:
Tenet Healthcare., an investor-owned health-care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities in the United States. The company's general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive care, critical care and/or coronary care units, physical therapy; and orthopedic, oncology, and outpatient services; tertiary care services, such as open-heart surgery, neonatal intensive care, and neuroscience; quaternary care in areas, including heart, liver, kidney, and bone marrow transplants, as well as burn services; gamma-knife brain surgery; and cyberknife radiation therapy for tumors and lesions in the brain, lung, neck, and spine.